2Leader WC, Chandler M, Castiglia M. Pharmaeikineties optimization of Vaneomyein therapy [ J ]. Clin Pharmacokinet, 1995. 28:327-342.
3Vance K, Rotschafer JC, Gilliland SS, et al. A comparative assessment of vancomycin associated nephrotoxicity in the young versus the elderly hospitalized patient[J]. J Antimicrob Chemother, 1994, 33(4): 811.
4Rybak MJ, Albrecht LM, Boike SC, et al. Nephrotoxicity of vancomycin, alone and with an aminoglycoside[J], J Antimicrob Chemother, 1990, 25(4): 679.
5Welty TE, Copa AK. Impact of vancomycin therapeutic drug monitoring on patient care[J]. Ann Pharmacother, 1994, 28(12): 1335.
